|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$0.17 |
$0.17 |
$0.15 |
$0.16 |
625.40K | 04/18/2024 |
$0.16 |
$0.17 |
$0.15 |
$0.15 |
664.50K | 04/19/2024 |
$0.15 |
$0.16 |
$0.14 |
$0.14 |
1.98M | 04/22/2024 |
$0.15 |
$0.15 |
$0.14 |
$0.15 |
1.88M | 04/23/2024 |
$11.42 |
$12.93 |
$11.15 |
$12.00 |
115.50K |
|
Pieris Pharmaceuticals is a biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. Co.'s clinical pipeline includes elarekibep an inhaled IL-4Ra antagonist Anticalin protein to treat uncontrolled asthma, PRS-220, an inhaled CTGF antagonist to treat IPF and other forms for fibrotic lung disease, an immuno-oncology (IO) bispecific PRS-344/S095012 targeting PD-L1 and 4-1BB. Co. has intellectual property rights directed to various aspects of its Anticalin technology platform, allowing for the development and improvement of both its platform and drug candidates. Co.'s development plans focus on its clinical and preclinical programs. | |
|
Pieris Pharmaceuticals (PIRS) has the following price history information. Looking back at PIRS historical stock prices for the last five trading days, on April 17, 2024, PIRS opened at $0.17, traded as high as $0.17 and as low as $0.15, and closed at $0.16. Trading volume was a total of 625.40K shares. On April 18, 2024, PIRS opened at $0.16, traded as high as $0.17 and as low as $0.15, and closed at $0.15. Trading volume was a total of 664.50K shares. On April 19, 2024, PIRS opened at $0.15, traded as high as $0.16 and as low as $0.14, and closed at $0.14. Trading volume was a total of 1.98M shares. On April 22, 2024, PIRS opened at $0.15, traded as high as $0.15 and as low as $0.14, and closed at $0.15. Trading volume was a total of 1.88M shares. On April 23, 2024, PIRS opened at $11.42, traded as high as $12.93 and as low as $11.15, and closed at $12.00. Trading volume was a total of 115.50K shares.
PIRS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Pieris Pharmaceuticals shares, starting with a $10,000 purchase of PIRS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/14/2015 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$280.00 |
|
End price/share: |
$12.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-95.71% |
|
Average Annual Total Return: |
-29.44% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$428.60 |
|
Years: |
9.03 |
|
|
|
Date |
Close |
04/17/2024 | $0.16 | 04/18/2024 | $0.15 | 04/19/2024 | $0.14 | 04/22/2024 | $0.15 | 04/23/2024 | $12.00 |
|
|